Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Simvastatin regulates oligodendroglial process dynamics and survival.
Kinin-mediated inflammation in neurodegenerative disorders.
Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.
Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
Dark microglia: A new phenotype predominantly associated with pathological states.
[Optic neuritis: diagnosis, treatment and clinical implications].
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse.
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Deafness in Patients with Multiple Sclerosis.
Fulminant demyelinating diseases.
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
Self-reported Depression and Physical Activity in Adults with Mobility Impairments.
Merck KGaA to try again to get approval for MS pill cladribine
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Anesthetic management of a parturient with neuromyelitis optica.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Combined oral contraceptives: health benefits beyond contraception.
Pages
« first
‹ previous
…
182
183
184
185
186
187
188
189
190
…
next ›
last »